| Title |
Continuous infusion of low-dose doxorubicin, epirubicin and mitoxantrone in cancer chemotherapy: A review
|
|---|---|
| Published in |
International Journal of Clinical Pharmacy, December 1988
|
| DOI | 10.1007/bf02219662 |
| Pubmed ID | |
| Authors |
Janke Greidanus, Pax H. B. Willemse, Donald R. A. Uges, Evrard T. H. G. J. Oremus, Zacharias J. de Langen, Elisabeth G. E. de Vries |
Attention Score in Context
This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 27 July 2010.
All research outputs
#8,534,528
of 25,371,288 outputs
Outputs from International Journal of Clinical Pharmacy
#632
of 1,578 outputs
Outputs of similar age
#10,279
of 53,877 outputs
Outputs of similar age from International Journal of Clinical Pharmacy
#1
of 3 outputs
Altmetric has tracked 25,371,288 research outputs across all sources so far. This one is in the 43rd percentile – i.e., 43% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,578 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.5. This one is in the 41st percentile – i.e., 41% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 53,877 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 21st percentile – i.e., 21% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 3 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them